Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study by Vyas, P, Hills, R, Knapper, S, Dennis, M, Drummond, M, Dillon, R, Pocock, C, Culligan, D, Wiseman, D, Zabkiewicz, J, Hodges, M, Cargo, C, Taylor, J, Upton, L, Wright, M, Bowen, D